Literature DB >> 23001091

Cerebrotendinous xanthomatosis: a rare disorder with a rare presentation.

N K Agrawal1, Sunny Garg.   

Abstract

A young man was brought for mental retardation, frequent non-bloody diarrhoea and swellings at ankles and elbow. He became bed-ridden due to cataract, mental retardation and pain in the back and lower limb. There were repeated pathological fractures and vitamin D deficiency without renal dysfunction. There were low low-density lipoprotein and triglyceride levels. MRI of the brain revealed hypointense lesions in cerebellar white matter, heterogenous hyperintensity in dentate nucleus and adjacent white matter, right basal ganglia and in the periventricular region with diffuse cerebral atrophy. T1-weighted MRI (ankle region) revealed bilaterally thickened and irregular achilles tendons with hyperintense masses surrounded by patchy hypointensities. A similar xanthomatous lesion (cholestanol deposits) was also present in the sacral region. Vitamin D and calcium supplementation and chenodeoxycholic acid therapy improved pain at lower limbs and body weight. Cerebrotendinous xanthomatosis is a rare autosomal-recessive familial mutation of the sterol 27 hydroxylase causing lipid metabolic disease.

Entities:  

Mesh:

Year:  2012        PMID: 23001091      PMCID: PMC4543233          DOI: 10.1136/bcr-2012-006202

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis.

Authors:  J R Cruysberg; R A Wevers; J J Tolboom
Journal:  Am J Ophthalmol       Date:  1991-11-15       Impact factor: 5.258

2.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

3.  Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism.

Authors:  A Federico; M T Dotti; F Loré; R Nuti
Journal:  J Neurol Sci       Date:  1993-03       Impact factor: 3.181

4.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

5.  Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.

Authors:  B J Koopman; B G Wolthers; J C van der Molen; W van der Slik; R J Waterreus; A van Spreeken
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

  5 in total
  2 in total

Review 1.  Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.

Authors:  Janice C Wong; Kailey Walsh; Douglas Hayden; Florian S Eichler
Journal:  J Inherit Metab Dis       Date:  2018-02-26       Impact factor: 4.982

2.  Bilateral Femoral Neck Fractures in Cerebrotendinous Xanthomatosis Treated by Hip Arthroplasties: The First Case Report and Literature Review.

Authors:  Witchuree Wejjakul; Swist Chatmaitri; Thongek Wattanarojanaporn; Anuwat Pongkunakorn; Chupong Ittiwut; Vorasuk Shotelersuk
Journal:  J Orthop Case Rep       Date:  2017 Sep-Oct
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.